ECHA Consults Over Proposal to Increase SVHC List to 233 Substances

SGS, the world’s leading testing, inspection and certification company, is advising stakeholders that the European Chemicals Agency (ECHA) has launched a consultation over its proposal to list nine new substances of very high concern (SVHC).

 

The 45-day consultation was launched on September 2, 2022, and relates to:

  • 1,1'-[ethane-1,2-diylbisoxy]bis[2,4,6-tribromobenzene] (BTBPE)
  • 2,2',6,6'-tetrabromo-4,4'-isopropylidenediphenol (Tetrabromobisphenol A (TBBPA))
  • 4,4'-sulphonyldiphenol (Bisphenol S (BPS))
  • Barium diboron tetraoxide
  • Bis(2-ethylhexyl) tetrabromophthalate covering any of the individual isomers and/or combinations thereof (TBPH)
  • Isobutyl 4-hydroxybenzoate (Isobutylparaben (IBP))
  • Melamine (1,3,5-triazine-2,4,6-triamine)
  • Perfluoroheptanoic acid and its salts (PFHpA and its salts)
  • Reaction mass of 2,2,3,3,5,5,6,6¬-octafluoro-4-(1,1,1,2,3,3,3-heptafluoro-propan-2-yl)morpholine and 2,2,3,3,5,5,6,6-octafluoro-(heptafluoro¬propyl) morpholine

 

Among this list are substances that are considered to be endocrine disrupting; carcinogenic 1B; toxic to reproduction 1B; persistent, bioaccumulative and toxic (PBT); and very persistent and very bioaccumulative (vPvB).

 

SGS has published SafeGuard 110.22 to give stakeholders further information on the classification and an indication of their potential applications.

 

The ECHA is accepting comments until October 17, 2022.

 

SGS SVHC Management Services

SGS offers a comprehensive range of services to help manufacturers and suppliers ensure their products are safe and comply with national and international regulations concerning harmful chemicals. In the end, it’s only trusted because it’s tested. Learn more about SGS SVHC Management Services.

 

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full ECHA Consults Over Nine Substances as SVHCs SafeGuardS.

 

Subscribe here to receive SGS SafeGuardS direct to your inbox.

 

For further information contact:

 

Dr. HingWo Tsang

Global Information and Innovation Manager

Tel: (+852) 2774 7420

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Website: www.sgs.com/cgnr

LinkedIn: sgs-consumer-goods-&-retail

 

About SGS

We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity. Our 96,000 employees operate a network of 2,600 offices and laboratories, working together to enable a better, safer and more interconnected world.

ClubShop joins the Raise Capital program of FasterCapital from the UK

ClubShop is currently raising capital to build a smart solution and system for buyers, entrepreneurs, and people who are interested in creating a side hustle!

Clubshop empowers consumers to build and enjoy an extra income without working extra hours or investing capital they don't have. The startup is building a democratized system for people to increase their income in simple and attainable ways. The startup is based in the United Kingdom and is cofounded by Fabrizio Perotti and Giuseppe Francavilla and is raising $5M. The team is comprised of serial entrepreneurs Fabrizio and Giuseppe who are passionate about ClubShop’s mission and technology and are ready to execute their vision. The startup has joined FasterCapital’s Raise Capital program which will help it in getting ready and matched with investors and VCs.


Mr. Hesham Zreik, CEO of FasterCapital, commented, “We are happy to be working with the team at ClubShop on this great mission. We believe in startups that offer smart solutions for people worldwide”


To contact the team at FasterCapital, feel free to reach out to the team at This email address is being protected from spambots. You need JavaScript enabled to view it. or via Whatsapp at +971 5558 55663

FasterCapital is Supporting Startups in MENA in order to Get Funded

Startups in MENA are not getting the support they need especially when it comes to funding. FasterCapital is an online incubator and accelerator that is based in Dubai and is helping more and more startups in MENA raise capital and grow.

Whether you are in the Ecommerce, the B2B, or any other sector, starting a business requires money that you might not currently have and so it requires funding. Startups and entrepreneurs struggle and sometimes fail because of the scarcity of funding and that is true especially in MENA. This is why helping startups get the funding they need is one of the main missions FasterCapital is working towards.

FasterCapital is an online incubator, accelerator, and service provider that helps startups and small businesses in MENA and worldwide and invests in them in a work-per-equity model. Through its Raise Capital program, FasterCapital is helping startups in MENA get matched with angels and VCs that are based in MENA and other international funding sources as well.
FasterCapital has a wide network of investors and VCs in MENA and it uses an AI system to create an accurate matching process. Not only that, but the team makes warm introduction to the investing parties to increase the success rate.
To learn more about the Raise Capital program and how FasterCapital can help you feel free to reach out to This email address is being protected from spambots. You need JavaScript enabled to view it.

US EPA Proposes Further Updates to Formaldehyde Standards for Composite Wood Products

SGS, the world’s leading testing, inspection and certification company, is advising stakeholders that the US Environmental Protection Agency (EPA) has proposed revisions to two additional voluntary consensus standards for formaldehyde emissions in composite wood products.

 

The EPA first issued a proposed rule to update seven voluntary consensus standards falling under 40 CFR 770 ‘Formaldehyde Standards for Composite Wood Products’ (Toxic Substances Control Act Title VI (TSCA Title VI)) in March 2022.

 

However, since the conclusion of the consultation period for those standards, two additional voluntary consensus standards have been updated. Therefore, on September 20, 2022, the EPA published a supplemental notice of proposed rulemaking (SNPRM) in the Federal Register (87 FR 57432) relating to:

  • A208.1-2016 updated to ANSI A208.1-2022 ‘Particleboard’
  • ANSI A208.2-2016 updated to ANSI A208.2-2022 ‘Medium Density Fiberboard (MDF) for Interior Applications’

 

The EPA will accept comments until October 20, 2022.

 

SGS Chemical Testing

SGS offers a comprehensive range of testing services to help manufacturers and suppliers ensure their products are safe and comply with national and international regulations concerning harmful chemicals. In the end, it’s only trusted because it’s tested. Learn more about SGS Chemical Testing Services.

 

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full US EPA Intends to Revise Formaldehyde Standards for Composite Wood Products SafeGuardS.

 

Subscribe here to receive SGS SafeGuardS direct to your inbox.

 

For further information contact:

 

Dr. HingWo Tsang

Global Information and Innovation Manager

Tel: (+852) 2774 7420

 

Ms Melanie Schubert

Senior Technical Manager

Tel: +1 312 414 9394

 

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Website: www.sgs.com/hardlines

LinkedIn: sgs-consumer-goods-&-retail

 

About SGS

We are SGS – the world’s leading testing, inspection and certification company. We are recognized as the global benchmark for quality and integrity. Our 96,000 employees operate a network of 2,600 offices and laboratories, working together to enable a better, safer and more interconnected world.

Recent Research Explores the United Arab Emirates Implantable Drug Delivery Devices Market 2028

The market study covers the United Arab Emirates Implantable Drug Delivery Devices Market crosswise segments. It purposes at estimating the market size and the growth prospective of the market segments, such as supplier, application, organization size, and business vertical. The study also includes a detailed competitive analysis of the key players in the market, along with their enterprise profiles, key observations related to product and industry offerings, new developments, and key market plans.

 To Know More Request a Sample of this Report@ https://www.infiniumglobalresearch.com/united-arab-emirates/sample-request/40919

We are Now Including the Impact Analysis of COVID-19 in this Premium Report and the Forecast Period of this Report shall be Revised to 2022-2028.

The Section on the Impact of COVID-19 on this Market is Included in the Report for Free.

A complete view of the implantable drug delivery devices industry is provided based on definitions, product classification, applications, and major players driving the United Arab Emirates implantable drug delivery devices market share and revenue. The information in the form of graphs, and pie charts will lead to an easy analysis of an industry. The market share of top leading players, their plans and business policies, and growth factors will help other players in gaining useful business tactics.

The forecast for the United Arab Emirates implantable drug delivery devices market information is based on the present market situation, growth opportunities, development factors, and the opinion of industry experts. An in-depth analysis of the company profiles, implantable drug delivery devices market revenue at the country level and its applications are conducted.  The analysis of downstream buyers, sales channels, raw materials, and industry verticals is offered in this report.

Anniversary Month Offer...! IGR Offering a 20% Discount on Its Reports.  Click Here and Get the Discount: https://www.infiniumglobalresearch.com/united-arab-emirates/customization/40919

Segments Covered in this Premium Report:

The report on the United Arab Emirates implantable drug delivery devices market provides a detailed analysis of segments in the market based on product type, technology, and applications.

Segmentation Based on Product Type

  • Coronary Drug-eluting Stent
  • Bio-absorbable Stent
  • Implantable Contraceptive Devices
  • Implantable Intraocular Devices
  • Drug Infusion Pumps
  • Brachytherapy Seeds

Segmentation Based on Technology

  • Bio-degradable
  • Non-biodegradable
  • Smart Pills

Segmentation Based on Applications

  • Ophthalmology
  • Cardiology
  • Contraceptive
  • Oncology

Highlights of the Report

The report provides detailed insights into:

 1) Demand and supply conditions of the implantable drug delivery devices market

 2) Factors affecting the implantable drug delivery devices market in the short run and the long run

 3) The dynamics including drivers, restraints, opportunities, political, socioeconomic factors, and technological factors

 4) Key trends and future prospects

 5) Leading companies operating in the implantable drug delivery devices market and their competitive position in the United Arab Emirates

 6) The dealers/distributors profiles provide basic information on the top 10 dealers & distributors operating in (the United Arab Emirates) the implantable drug delivery devices market

 7) IGR Matrix: to position the product types

 8) Market estimates up to 2028

 The report answers questions such as:

 1) What is the market size of the implantable drug delivery devices market in the United Arab Emirates?

 2) What are the factors that affect the growth in the implantable drug delivery devices market over the forecast period?

 3) What is the competitive position in the United Arab Emirates implantable drug delivery devices market?

 4) What are the opportunities in the United Arab Emirates implantable drug delivery devices market?

 5) What are the modes of entering the United Arab Emirates implantable drug delivery devices market?

Table of Content

Chapter 1.     Report Overview

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2.     Executive Summary

Chapter 3.     Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

3.3. PEST-Analysis

3.4. Porter’s Diamond Model for the United Arab Emirates Implantable Drug Delivery Devices Market

3.5. IGR-Growth Matrix Analysis

3.6. Competitive Landscape in the United Arab Emirates Implantable Drug Delivery Devices Market

Chapter 4.     United Arab Emirates Implantable Drug Delivery Devices Market by Product Type

4.1. Coronary Drug-eluting Stent

4.2. Bio-absorbable Stent

4.3. Implantable Contraceptive Devices

4.4. Implantable Intraocular Devices

4.5. Drug Infusion Pumps

4.6. Brachytherapy Seeds

Chapter 5.     United Arab Emirates Implantable Drug Delivery Devices Market by Technology

5.1. Bio-degradable

5.2. Non-biodegradable

5.3. Smart Pills

Chapter 6.     United Arab Emirates Implantable Drug Delivery Devices Market by Applications

6.1. Ophthalmology

6.2. Cardiology

6.3. Contraceptive

6.4. Oncology

Chapter 7.     Company Profiles

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.infiniumglobalresearch.com/united-arab-emirates/enquiry/40919

Research Methodology:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the implantable drug delivery devices market. Moreover, the study highlights current market trends and provides forecasts for 2022-2028. We also have highlighted future trends in the market that will affect the demand during the forecast period.